Data obtained by large observational studies and meta-analysis indicate the absence of an increased risk of lymphoma related to therapy with anti-TNF-α, but there is limited information in literature about the safety of sequential, multiple biological agents therapy for a time longer than three years. We hereby present a case of psoriatic arthritis developing non-Hodgkin lymphoma after a six-year history of poorly effective therapy with different anti-TNF-α.
Non-Hodgkin Lymphoma in Psoriatic Arthritis Treated with Sequential, Multiple Anti-TNF-α Agents: A Case Report / Sandri, Gilda; Cestelli, Valentina; Liardo, ELIANA VALENTINA; Sacchi, Stefano; Mascia, Maria Teresa. - In: RHEUMATOLOGY. - ISSN 2161-1149. - ELETTRONICO. - 03:(2013), pp. 1-3. [10.4172/2161-1149.1000123]
Non-Hodgkin Lymphoma in Psoriatic Arthritis Treated with Sequential, Multiple Anti-TNF-α Agents: A Case Report
SANDRI, Gilda;LIARDO, ELIANA VALENTINA;SACCHI, Stefano;MASCIA, Maria Teresa
2013
Abstract
Data obtained by large observational studies and meta-analysis indicate the absence of an increased risk of lymphoma related to therapy with anti-TNF-α, but there is limited information in literature about the safety of sequential, multiple biological agents therapy for a time longer than three years. We hereby present a case of psoriatic arthritis developing non-Hodgkin lymphoma after a six-year history of poorly effective therapy with different anti-TNF-α.File | Dimensione | Formato | |
---|---|---|---|
non-hodgkin-lymphoma-in-psoriatic-arthritis-treated-with-sequential-multiple-anti-tnf-agents-case-report-2161-1149.1000123.pdf
Open access
Descrizione: articolo principale
Tipologia:
VOR - Versione pubblicata dall'editore
Dimensione
624.76 kB
Formato
Adobe PDF
|
624.76 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris